The component of SSPW1 was analyzed by gas chromatography, which contained 48.92% neutral sugars, 5.56% proteins and 42.83% glyoxylates
Women's Health Leadership In addition to product innovation, Kyowa served as the Women's Health category sponsor at SupplySide Global 2025, a role that aligns perfectly with the company's research focus and leadership team
Safety, Legality, and Ethical Considerations Peptide therapy for autoimmune disease remains largely experimental
For semaglutide, the maintenance dose for weight management is 2.4 mg weekly, significantly higher than the 0.5-1.0 mg doses used for diabetes management
The robust weight loss combined with a well-tolerated safety profile reinforces our confidence in the clinical development programme [of CT-388] as we advance to phase III trials" Dr Levi Garraway, PhD, Roches Chief Medical Officer and Head of Global Product Development, said: We are pleased to see such meaningful weight loss in people treated with CT-388